Annual Accounts Payable
$2.15 M
+$734.00 K+52.02%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual accounts payable is $2.15 million, with the most recent change of +$734.00 thousand (+52.02%) on December 31, 2023.
- During the last 3 years, VVOS annual accounts payable has risen by +$1.36 million (+174.65%).
- VVOS annual accounts payable is now at all-time high.
Performance
VVOS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.07 M
-$953.00 K-46.99%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly accounts payable is $1.07 million, with the most recent change of -$953.00 thousand (-46.99%) on September 30, 2024.
- Over the past year, VVOS quarterly accounts payable has stayed the same.
- VVOS quarterly accounts payable is now -56.98% below its all-time high of $2.50 million, reached on March 31, 2024.
Performance
VVOS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VVOS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +52.0% | 0.0% |
| 3 y3 years | +174.7% | +53.5% |
| 5 y5 years | +352.4% | +23.6% |
VVOS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +133.2% | -57.0% | +66.9% |
| 5 y | 5-year | at high | +174.7% | -57.0% | +66.9% |
| alltime | all time | at high | +352.4% | -57.0% | +66.9% |
Vivos Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.07 M(-47.0%) |
| Jun 2024 | - | $2.03 M(-18.8%) |
| Mar 2024 | - | $2.50 M(+16.5%) |
| Dec 2023 | $2.15 M(+52.0%) | $2.15 M(+40.4%) |
| Sep 2023 | - | $1.53 M(+15.3%) |
| Jun 2023 | - | $1.32 M(-11.4%) |
| Mar 2023 | - | $1.50 M(+6.0%) |
| Dec 2022 | $1.41 M | $1.41 M(+119.1%) |
| Sep 2022 | - | $644.00 K(-48.6%) |
| Jun 2022 | - | $1.25 M(+42.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $877.00 K(-4.7%) |
| Dec 2021 | $920.00 K(+17.8%) | $920.00 K(+31.4%) |
| Sep 2021 | - | $700.20 K(-46.1%) |
| Jun 2021 | - | $1.30 M(+49.3%) |
| Mar 2021 | - | $869.70 K(+11.4%) |
| Dec 2020 | $781.00 K(-27.9%) | $781.00 K(-49.0%) |
| Sep 2020 | - | $1.53 M(+16.8%) |
| Jun 2020 | - | $1.31 M(+20.9%) |
| Dec 2019 | $1.08 M(+128.5%) | $1.08 M |
| Dec 2018 | $474.10 K | - |
FAQ
- What is Vivos Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Vivos Therapeutics?
- What is Vivos Therapeutics annual accounts payable year-on-year change?
- What is Vivos Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly accounts payable year-on-year change?
What is Vivos Therapeutics annual accounts payable?
The current annual accounts payable of VVOS is $2.15 M
What is the all time high annual accounts payable for Vivos Therapeutics?
Vivos Therapeutics all-time high annual accounts payable is $2.15 M
What is Vivos Therapeutics annual accounts payable year-on-year change?
Over the past year, VVOS annual accounts payable has changed by +$734.00 K (+52.02%)
What is Vivos Therapeutics quarterly accounts payable?
The current quarterly accounts payable of VVOS is $1.07 M
What is the all time high quarterly accounts payable for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly accounts payable is $2.50 M
What is Vivos Therapeutics quarterly accounts payable year-on-year change?
Over the past year, VVOS quarterly accounts payable has changed by $0.00 (0.00%)